Insulin resistance may contribute significantly to the development of MASLD and its induced abnormalities in lipid metabolism can lead to increased production of proinflammatory cytokines, such as TNF-α, IL-1b, and IL-6, as well as less adiponectin, thereby inducing systemic insulin resistance (39). This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.